Doxofylline Syrup 100 mg/5 ml, 200 mg/5 ml, Suppliers & Bulk Manufacturers

Available Forms: Oral Syrup

Available Strengths: 100 mg/5 ml, 200 mg/5 ml,

Reference Brands: Doxolin (India), Doxofyl (India/LATAM)

Category: Respiratory Disorder

Doxofylline is a methylxanthine derivative used in chronic obstructive pulmonary disease, asthma, and bronchospasms.

Product Description:

Doxofylline is a xanthine-derived bronchodilator used in the management of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis. It works by relaxing the smooth muscles of the airways, leading to bronchodilation and improved airflow, thereby helping patients breathe more easily. Doxofylline has been widely studied and is considered to have comparable efficacy to theophylline in controlling respiratory symptoms, but with a significantly improved safety profile and fewer side effects, particularly related to the cardiovascular and central nervous systems.

This makes it a preferred alternative in many clinical settings where long-term bronchodilator therapy is required. In addition to asthma and COPD, doxofylline has shown potential benefits in the treatment of bronchiectasis, and in 2014, it received orphan drug designation from the US Food and Drug Administration (FDA) for this indication. The drug is generally well tolerated, with mild side effects such as nausea, headache, or gastrointestinal discomfort reported in some patients. It is available in various dosage forms including tablets and syrups and is widely used across global markets for effective respiratory care.